Bitcoin, Ethereum, XRP, Dogecoin Dip, But Traders Remain Optimistic For One Reason Major cryptocurrencies are in the red as macro uncertainty and trade war tensions weigh on sentiment.
Palantir Stock Is On Fire This Week, Outpacing Broader Markets: What's Going On? Palantir Technologies Inc (
NASDAQ:PLTR ) shares are rising on Tuesday despite a pullback in broader markets. The stock appears to be moving on continued momentum after the company announced that NATO acquired one of its AI-powered military systems.
Riot Platforms Stock Is Nearing 52-Week Lows: What's Going On? (CORRECTED) Shares of Riot Platforms Inc. (
NASDAQ: RIOT ) are trading lower Monday, nearing 52-week lows as crypto-linked stocks continue to face selling pressure amid broad investor caution and recent company updates.
Netflix May Fail At Achieving $1 Trillion Market Cap Netflix is reportedly eyeing $1 trillion valuation by the end of this decade.
ETFs For The Brave: Are These High-Octane Funds Your Best Bet To Ride An Upward Market Swing? Certain ETFs are best suited for when markets are rebounding, while others, like Invesco QQQ Trust, are for those who prefer to play it safe.
Novavax Covid Vaccine Shows Milder Side Effects Than Pfizer-BioNTech's Shot: Study Novavax updated Covid vaccine showed fewer and milder side effects than Pfizer-BioNTech's in a Utah study.
What's Going On With American Airlines Stock Today? American Airlines stock rises as it announces free inflight Wi-Fi for AAdvantage members through a new partnership with AT&T.
Dow Downgraded: Analyst Blames 'Perfect Storm' Of Weak Macro, High Costs, Trade Barriers BofA downgrades Dow to Underperform, citing macro headwinds, tariff risks, and growing pressure on dividend sustainability.
Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet-Based Peptide Delivery Merck signs deal with Austria's Cyprumed to develop oral peptide therapies, potentially paying up to $493 million for access to delivery technology.
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch Mounjaro's launch in India sparks a surge in patient demand as Eli Lilly gains a market edge ahead of Novo Nordisk and upcoming generic competition.
Bank Earnings Recap: Which One Is Best Positioned For 2025? A potential fed funds rate easing could further amplify their gains in the short-run.
